Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.34017153 |
2 | modulation by symbiont of host defense response (GO:0052031) | 6.34017153 |
3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.34017153 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.34017153 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.34017153 |
6 | modulation by symbiont of host immune response (GO:0052553) | 6.34017153 |
7 | detection of molecule of bacterial origin (GO:0032490) | 6.08041861 |
8 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.66701235 |
9 | microglial cell activation (GO:0001774) | 5.27408597 |
10 | macrophage activation involved in immune response (GO:0002281) | 5.02163656 |
11 | negative regulation of cell killing (GO:0031342) | 4.72953118 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.72953118 |
13 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.60822917 |
14 | detection of external biotic stimulus (GO:0098581) | 4.46507935 |
15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.44648904 |
16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.42850019 |
17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.32356392 |
18 | response to host immune response (GO:0052572) | 4.32301139 |
19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.32301139 |
20 | neutrophil mediated immunity (GO:0002446) | 4.30123445 |
21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.29366061 |
22 | detection of other organism (GO:0098543) | 4.21182423 |
23 | cellular extravasation (GO:0045123) | 4.19201171 |
24 | macrophage activation (GO:0042116) | 4.18295518 |
25 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.98528817 |
26 | neutrophil activation involved in immune response (GO:0002283) | 3.98454862 |
27 | response to peptidoglycan (GO:0032494) | 3.92819119 |
28 | response to host defenses (GO:0052200) | 3.91031870 |
29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.91031870 |
30 | response to host (GO:0075136) | 3.91031870 |
31 | detection of biotic stimulus (GO:0009595) | 3.85023778 |
32 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.78366252 |
33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.78204775 |
34 | neutrophil activation (GO:0042119) | 3.74917024 |
35 | myeloid leukocyte mediated immunity (GO:0002444) | 3.56968295 |
36 | negative regulation of interleukin-12 production (GO:0032695) | 3.51231539 |
37 | detection of bacterium (GO:0016045) | 3.48936510 |
38 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.44972039 |
39 | negative regulation of B cell mediated immunity (GO:0002713) | 3.44972039 |
40 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.42475407 |
41 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.40776804 |
42 | cellular response to interleukin-15 (GO:0071350) | 3.37267777 |
43 | response to interleukin-15 (GO:0070672) | 3.33282745 |
44 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.31220788 |
45 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.22782984 |
46 | leukocyte aggregation (GO:0070486) | 3.21586346 |
47 | activated T cell proliferation (GO:0050798) | 3.20587846 |
48 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.18955978 |
49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15514584 |
50 | granulocyte activation (GO:0036230) | 3.12844946 |
51 | respiratory burst (GO:0045730) | 3.07290879 |
52 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.06218166 |
53 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.04311379 |
54 | negative regulation of neurotransmitter transport (GO:0051589) | 3.04311176 |
55 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03038392 |
56 | positive regulation of mast cell activation (GO:0033005) | 2.98989127 |
57 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.97893109 |
58 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.96457109 |
59 | dendritic cell migration (GO:0036336) | 2.96345677 |
60 | myeloid cell activation involved in immune response (GO:0002275) | 2.95446042 |
61 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.94920842 |
62 | negative regulation of adaptive immune response (GO:0002820) | 2.94759056 |
63 | neural tube formation (GO:0001841) | 2.94198816 |
64 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.93455346 |
65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92567792 |
66 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91277190 |
67 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90463206 |
68 | olfactory bulb development (GO:0021772) | 2.87403988 |
69 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.85627981 |
70 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.84805220 |
71 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82695855 |
72 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82695855 |
73 | T-helper 1 type immune response (GO:0042088) | 2.82466911 |
74 | regulation of mast cell activation (GO:0033003) | 2.81012264 |
75 | radial glial cell differentiation (GO:0060019) | 2.80961081 |
76 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.79063230 |
77 | negative thymic T cell selection (GO:0045060) | 2.77116351 |
78 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72174171 |
79 | negative regulation of B cell proliferation (GO:0030889) | 2.65672001 |
80 | regulation of macrophage cytokine production (GO:0010935) | 2.64400117 |
81 | B cell receptor signaling pathway (GO:0050853) | 2.64116100 |
82 | negative T cell selection (GO:0043383) | 2.62526021 |
83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59966683 |
84 | presynaptic membrane assembly (GO:0097105) | 2.59461757 |
85 | tongue development (GO:0043586) | 2.57026835 |
86 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56617477 |
87 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.56438265 |
88 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.55844417 |
89 | neutrophil chemotaxis (GO:0030593) | 2.54841526 |
90 | regulation of mast cell degranulation (GO:0043304) | 2.53977520 |
91 | I-kappaB phosphorylation (GO:0007252) | 2.50724859 |
92 | germinal center formation (GO:0002467) | 2.49794569 |
93 | positive regulation of macrophage cytokine production (GO:0060907) | 2.48247736 |
94 | neutrophil migration (GO:1990266) | 2.48181391 |
95 | cytokine secretion (GO:0050663) | 2.46664738 |
96 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.44498011 |
97 | negative regulation of interleukin-1 production (GO:0032692) | 2.40690169 |
98 | defense response to protozoan (GO:0042832) | 2.40496620 |
99 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.39935154 |
100 | positive regulation of mast cell degranulation (GO:0043306) | 2.39935154 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.02498839 |
2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.84256719 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.83168469 |
4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.78568065 |
5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.73985149 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.72995950 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.64408013 |
8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.57440248 |
9 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.44299094 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.33237872 |
11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.09689550 |
12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06293921 |
13 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.94904104 |
14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.93781983 |
15 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.92326446 |
16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86972534 |
17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.82396491 |
18 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.81999323 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81187518 |
20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80546153 |
21 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79424147 |
22 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.73651463 |
23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73148147 |
24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72432642 |
25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67830357 |
26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65850731 |
27 | TP53_16413492_ChIP-PET_HCT116_Human | 1.65597950 |
28 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59892862 |
29 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55511977 |
30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53592702 |
31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.53050105 |
32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47948419 |
33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46398755 |
34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45960912 |
35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45338282 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44568083 |
37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44051264 |
38 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41158924 |
39 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.41158924 |
40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39542451 |
41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38966347 |
42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.37620301 |
43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37540599 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37079597 |
45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36494767 |
46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36267921 |
47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35009967 |
48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34366269 |
49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28157498 |
50 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28016713 |
51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24455363 |
52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22698691 |
53 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21800347 |
54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17122189 |
55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17049168 |
56 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16726247 |
57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16620432 |
58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14905403 |
59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14525553 |
60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12764429 |
61 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12698169 |
62 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11257167 |
63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11236798 |
64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11056824 |
65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11020001 |
66 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10719122 |
67 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10242276 |
68 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.08572857 |
69 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08366422 |
70 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.08149830 |
71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07250140 |
72 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07192388 |
73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06797925 |
74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05886748 |
75 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05778826 |
76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05778826 |
77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05669161 |
78 | MYB_26560356_Chip-Seq_TH2_Human | 1.04998050 |
79 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03354504 |
80 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03293932 |
81 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03155169 |
82 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02909734 |
83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02552052 |
84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02552052 |
85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.02505925 |
86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01372828 |
87 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00765469 |
88 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00026871 |
89 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99353028 |
90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99283880 |
91 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98661480 |
92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98276074 |
93 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98200677 |
94 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97594982 |
95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97020296 |
96 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97010298 |
97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96300766 |
98 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95959847 |
99 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95783407 |
100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95597553 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 5.97588918 |
2 | MP0000569_abnormal_digit_pigmentation | 4.03122209 |
3 | MP0003303_peritoneal_inflammation | 3.04257921 |
4 | MP0005248_abnormal_Harderian_gland | 2.92569718 |
5 | MP0003436_decreased_susceptibility_to | 2.64504085 |
6 | MP0002419_abnormal_innate_immunity | 2.49130439 |
7 | MP0001835_abnormal_antigen_presentation | 2.33529526 |
8 | MP0002277_abnormal_respiratory_mucosa | 2.19297866 |
9 | MP0002928_abnormal_bile_duct | 2.15881889 |
10 | MP0003828_pulmonary_edema | 2.11229315 |
11 | MP0001800_abnormal_humoral_immune | 2.07069258 |
12 | MP0006082_CNS_inflammation | 2.06874432 |
13 | MP0006292_abnormal_olfactory_placode | 2.05987178 |
14 | MP0004883_abnormal_blood_vessel | 2.04010633 |
15 | MP0008260_abnormal_autophagy | 2.02145551 |
16 | MP0003690_abnormal_glial_cell | 1.90231568 |
17 | MP0009785_altered_susceptibility_to | 1.87136432 |
18 | MP0002723_abnormal_immune_serum | 1.75274524 |
19 | MP0008789_abnormal_olfactory_epithelium | 1.73075852 |
20 | MP0005025_abnormal_response_to | 1.73015707 |
21 | MP0000685_abnormal_immune_system | 1.71891914 |
22 | MP0003183_abnormal_peptide_metabolism | 1.69224379 |
23 | MP0002420_abnormal_adaptive_immunity | 1.68274167 |
24 | MP0009764_decreased_sensitivity_to | 1.67175625 |
25 | MP0002452_abnormal_antigen_presenting | 1.63684344 |
26 | MP0001819_abnormal_immune_cell | 1.62921957 |
27 | MP0005000_abnormal_immune_tolerance | 1.62258523 |
28 | MP0003880_abnormal_central_pattern | 1.62049537 |
29 | MP0005671_abnormal_response_to | 1.61173866 |
30 | MP0002653_abnormal_ependyma_morphology | 1.60541413 |
31 | MP0001486_abnormal_startle_reflex | 1.55711333 |
32 | MP0000778_abnormal_nervous_system | 1.51693621 |
33 | MP0005387_immune_system_phenotype | 1.45966635 |
34 | MP0001790_abnormal_immune_system | 1.45966635 |
35 | MP0003191_abnormal_cellular_cholesterol | 1.44753923 |
36 | MP0002405_respiratory_system_inflammati | 1.41533403 |
37 | MP0003300_gastrointestinal_ulcer | 1.38523024 |
38 | MP0006054_spinal_hemorrhage | 1.38457172 |
39 | MP0005084_abnormal_gallbladder_morpholo | 1.36752082 |
40 | MP0004381_abnormal_hair_follicle | 1.35276412 |
41 | MP0005164_abnormal_response_to | 1.34148039 |
42 | MP0003045_fibrosis | 1.32259946 |
43 | MP0004484_altered_response_of | 1.31832483 |
44 | MP0001533_abnormal_skeleton_physiology | 1.31328568 |
45 | MP0005394_taste/olfaction_phenotype | 1.27709639 |
46 | MP0005499_abnormal_olfactory_system | 1.27709639 |
47 | MP0005310_abnormal_salivary_gland | 1.27475520 |
48 | MP0002132_abnormal_respiratory_system | 1.26704697 |
49 | MP0005174_abnormal_tail_pigmentation | 1.24481205 |
50 | MP0005388_respiratory_system_phenotype | 1.18489504 |
51 | MP0002133_abnormal_respiratory_system | 1.18489504 |
52 | MP0000465_gastrointestinal_hemorrhage | 1.18034880 |
53 | MP0000427_abnormal_hair_cycle | 1.16371215 |
54 | MP0003011_delayed_dark_adaptation | 1.16317747 |
55 | MP0000716_abnormal_immune_system | 1.13006165 |
56 | MP0003787_abnormal_imprinting | 1.12546775 |
57 | MP0002168_other_aberrant_phenotype | 1.09536490 |
58 | MP0009053_abnormal_anal_canal | 1.07647906 |
59 | MP0001958_emphysema | 1.05864897 |
60 | MP0000516_abnormal_urinary_system | 1.05650037 |
61 | MP0005367_renal/urinary_system_phenotyp | 1.05650037 |
62 | MP0004885_abnormal_endolymph | 1.04788071 |
63 | MP0009278_abnormal_bone_marrow | 1.04163036 |
64 | MP0003195_calcinosis | 1.03416374 |
65 | MP0002398_abnormal_bone_marrow | 1.00286409 |
66 | MP0000015_abnormal_ear_pigmentation | 0.99513079 |
67 | MP0000920_abnormal_myelination | 0.99007615 |
68 | MP0002148_abnormal_hypersensitivity_rea | 0.98667328 |
69 | MP0003252_abnormal_bile_duct | 0.97438120 |
70 | MP0003656_abnormal_erythrocyte_physiolo | 0.94840784 |
71 | MP0003938_abnormal_ear_development | 0.93548498 |
72 | MP0001845_abnormal_inflammatory_respons | 0.93434216 |
73 | MP0001851_eye_inflammation | 0.91454725 |
74 | MP0005397_hematopoietic_system_phenotyp | 0.91346227 |
75 | MP0001545_abnormal_hematopoietic_system | 0.91346227 |
76 | MP0003075_altered_response_to | 0.86047051 |
77 | MP0003633_abnormal_nervous_system | 0.85682735 |
78 | MP0003172_abnormal_lysosome_physiology | 0.84721373 |
79 | MP0002332_abnormal_exercise_endurance | 0.81215829 |
80 | MP0000613_abnormal_salivary_gland | 0.81166387 |
81 | MP0003943_abnormal_hepatobiliary_system | 0.79833868 |
82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79362611 |
83 | MP0001177_atelectasis | 0.77604657 |
84 | MP0000631_abnormal_neuroendocrine_gland | 0.75105905 |
85 | MP0000689_abnormal_spleen_morphology | 0.75085498 |
86 | MP0002722_abnormal_immune_system | 0.74790561 |
87 | MP0005451_abnormal_body_composition | 0.73051747 |
88 | MP0000703_abnormal_thymus_morphology | 0.72772875 |
89 | MP0001986_abnormal_taste_sensitivity | 0.72332671 |
90 | MP0000566_synostosis | 0.69511580 |
91 | MP0003866_abnormal_defecation | 0.69382338 |
92 | MP0005167_abnormal_blood-brain_barrier | 0.69014959 |
93 | MP0005253_abnormal_eye_physiology | 0.68810617 |
94 | MP0003121_genomic_imprinting | 0.67825316 |
95 | MP0004142_abnormal_muscle_tone | 0.66856170 |
96 | MP0004130_abnormal_muscle_cell | 0.66388866 |
97 | MP0002396_abnormal_hematopoietic_system | 0.65792528 |
98 | MP0002429_abnormal_blood_cell | 0.65476975 |
99 | MP0001324_abnormal_eye_pigmentation | 0.65376709 |
100 | MP0005075_abnormal_melanosome_morpholog | 0.65284417 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Orchitis (HP:0100796) | 4.88613193 |
2 | Optic neuritis (HP:0100653) | 4.88227242 |
3 | Retrobulbar optic neuritis (HP:0100654) | 4.88227242 |
4 | Myositis (HP:0100614) | 4.60714705 |
5 | Recurrent bacterial skin infections (HP:0005406) | 4.53289659 |
6 | Recurrent abscess formation (HP:0002722) | 4.37393413 |
7 | Eczematoid dermatitis (HP:0000976) | 4.31476039 |
8 | Hypochromic microcytic anemia (HP:0004840) | 4.12249303 |
9 | Stomatitis (HP:0010280) | 4.01554510 |
10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.68266265 |
11 | Keratoconjunctivitis sicca (HP:0001097) | 3.63781812 |
12 | Keratoconjunctivitis (HP:0001096) | 3.48811681 |
13 | Gastrointestinal infarctions (HP:0005244) | 3.35164622 |
14 | Short 4th metacarpal (HP:0010044) | 3.34803466 |
15 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.34803466 |
16 | Recurrent fungal infections (HP:0002841) | 3.10614819 |
17 | Peritonitis (HP:0002586) | 3.06868687 |
18 | Amyotrophic lateral sclerosis (HP:0007354) | 3.06151992 |
19 | Abnormality of macrophages (HP:0004311) | 3.03269675 |
20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98911151 |
21 | True hermaphroditism (HP:0010459) | 2.97651341 |
22 | Hemiplegia (HP:0002301) | 2.94495513 |
23 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.93549168 |
24 | Recurrent cutaneous fungal infections (HP:0011370) | 2.93549168 |
25 | Recurrent skin infections (HP:0001581) | 2.91405155 |
26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.87107385 |
27 | Encephalitis (HP:0002383) | 2.84467037 |
28 | Episodic fever (HP:0001954) | 2.80924284 |
29 | Mediastinal lymphadenopathy (HP:0100721) | 2.79981934 |
30 | Papillary thyroid carcinoma (HP:0002895) | 2.73948050 |
31 | Spontaneous hematomas (HP:0007420) | 2.70929907 |
32 | Chest pain (HP:0100749) | 2.69500778 |
33 | Difficulty running (HP:0009046) | 2.67688222 |
34 | Hypochromic anemia (HP:0001931) | 2.50691636 |
35 | Stomach cancer (HP:0012126) | 2.50127895 |
36 | Abnormality of the 4th metacarpal (HP:0010012) | 2.49555407 |
37 | Meningitis (HP:0001287) | 2.46449257 |
38 | Hemoptysis (HP:0002105) | 2.38650184 |
39 | Pancreatic fibrosis (HP:0100732) | 2.37572038 |
40 | Subacute progressive viral hepatitis (HP:0006572) | 2.34460110 |
41 | Pancreatic cysts (HP:0001737) | 2.27906784 |
42 | Urticaria (HP:0001025) | 2.25315281 |
43 | Vasculitis (HP:0002633) | 2.24745675 |
44 | Gingivitis (HP:0000230) | 2.24732845 |
45 | Leukocytosis (HP:0001974) | 2.24335405 |
46 | Aqueductal stenosis (HP:0002410) | 2.23074298 |
47 | Toxemia of pregnancy (HP:0100603) | 2.22491246 |
48 | Arterial thrombosis (HP:0004420) | 2.18805517 |
49 | Abnormality of T cell number (HP:0011839) | 2.18312111 |
50 | Abnormality of the pleura (HP:0002103) | 2.17866028 |
51 | T lymphocytopenia (HP:0005403) | 2.15733163 |
52 | Widely spaced teeth (HP:0000687) | 2.15492426 |
53 | Hyperventilation (HP:0002883) | 2.10547140 |
54 | Obstructive lung disease (HP:0006536) | 2.08931915 |
55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08931915 |
56 | Abnormality of incisor morphology (HP:0011063) | 2.06105256 |
57 | Abnormality of the peritoneum (HP:0002585) | 2.04847129 |
58 | Keratitis (HP:0000491) | 2.04500996 |
59 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.04160818 |
60 | Gingival bleeding (HP:0000225) | 2.03414278 |
61 | Excessive salivation (HP:0003781) | 2.03186130 |
62 | Papilledema (HP:0001085) | 2.00274354 |
63 | Pulmonary infiltrates (HP:0002113) | 1.98402455 |
64 | Progressive cerebellar ataxia (HP:0002073) | 1.98106688 |
65 | Vitreoretinal degeneration (HP:0000655) | 1.96137415 |
66 | Oligodactyly (HP:0012165) | 1.92998259 |
67 | Pulmonary embolism (HP:0002204) | 1.91520519 |
68 | Genetic anticipation (HP:0003743) | 1.90447810 |
69 | Facial hemangioma (HP:0000329) | 1.88619924 |
70 | Microcytic anemia (HP:0001935) | 1.86547672 |
71 | Abnormality of the endocardium (HP:0004306) | 1.85604284 |
72 | Palpebral edema (HP:0100540) | 1.84647862 |
73 | Tented upper lip vermilion (HP:0010804) | 1.83364150 |
74 | Abnormality of the aortic arch (HP:0012303) | 1.79784945 |
75 | Drooling (HP:0002307) | 1.77591136 |
76 | Gangrene (HP:0100758) | 1.77041516 |
77 | Increased IgE level (HP:0003212) | 1.76628927 |
78 | Viral hepatitis (HP:0006562) | 1.75529097 |
79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74951761 |
80 | Postural instability (HP:0002172) | 1.73958784 |
81 | Megalencephaly (HP:0001355) | 1.73852698 |
82 | Eosinophilia (HP:0001880) | 1.73092527 |
83 | Panhypogammaglobulinemia (HP:0003139) | 1.71548503 |
84 | Febrile seizures (HP:0002373) | 1.70855488 |
85 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.70004563 |
86 | Postaxial foot polydactyly (HP:0001830) | 1.67245781 |
87 | Choroideremia (HP:0001139) | 1.65249873 |
88 | Long clavicles (HP:0000890) | 1.63948172 |
89 | Abnormality of the lower motor neuron (HP:0002366) | 1.63423196 |
90 | Abnormality of salivation (HP:0100755) | 1.63279232 |
91 | Hemiparesis (HP:0001269) | 1.63012970 |
92 | Sepsis (HP:0100806) | 1.62671821 |
93 | Abnormality of the metopic suture (HP:0005556) | 1.62011474 |
94 | Vertigo (HP:0002321) | 1.60395078 |
95 | Chronic hepatic failure (HP:0100626) | 1.60065551 |
96 | Split foot (HP:0001839) | 1.59812968 |
97 | Vertebral arch anomaly (HP:0008438) | 1.59428959 |
98 | Anorexia (HP:0002039) | 1.59084363 |
99 | Increased corneal curvature (HP:0100692) | 1.57381768 |
100 | Keratoconus (HP:0000563) | 1.57381768 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 3.39917164 |
2 | BLK | 2.99064431 |
3 | IRAK4 | 2.90013593 |
4 | FRK | 2.48677337 |
5 | CSK | 2.23652860 |
6 | EPHA3 | 2.19384684 |
7 | EPHB1 | 2.16899070 |
8 | YES1 | 2.12317868 |
9 | IRAK1 | 2.07478391 |
10 | MAP2K3 | 1.91423537 |
11 | SGK2 | 1.82064074 |
12 | TYK2 | 1.80706691 |
13 | FES | 1.68775832 |
14 | TNK2 | 1.64526883 |
15 | NTRK3 | 1.52002069 |
16 | TNIK | 1.50799453 |
17 | MAPK13 | 1.44810227 |
18 | MAP4K2 | 1.42377171 |
19 | KSR1 | 1.37329391 |
20 | HCK | 1.37255495 |
21 | TAOK3 | 1.36843260 |
22 | PTK2B | 1.36628487 |
23 | IRAK2 | 1.36023961 |
24 | SGK3 | 1.32004469 |
25 | MAP3K2 | 1.31002645 |
26 | JAK2 | 1.29702387 |
27 | CASK | 1.26998219 |
28 | FGR | 1.26397128 |
29 | KSR2 | 1.23144384 |
30 | TAOK1 | 1.21349529 |
31 | MAP4K1 | 1.21339179 |
32 | DYRK3 | 1.19173568 |
33 | SGK494 | 1.18155327 |
34 | SGK223 | 1.18155327 |
35 | BMPR2 | 1.17994197 |
36 | EPHB2 | 1.13905669 |
37 | PINK1 | 1.13124677 |
38 | GRK6 | 1.12634730 |
39 | WNK1 | 1.09785326 |
40 | SIK3 | 1.06536878 |
41 | MAP3K6 | 1.06509260 |
42 | LYN | 1.06333273 |
43 | MAP2K4 | 1.05985312 |
44 | WNK3 | 1.02674900 |
45 | JAK1 | 1.02350200 |
46 | SYK | 1.02287194 |
47 | BCR | 1.00783640 |
48 | BRSK2 | 1.00563382 |
49 | ZAP70 | 0.98541038 |
50 | FGFR2 | 0.96837653 |
51 | NTRK2 | 0.96169510 |
52 | BTK | 0.93922449 |
53 | STK11 | 0.91596539 |
54 | RAF1 | 0.91558814 |
55 | TXK | 0.91495295 |
56 | CDK19 | 0.91357589 |
57 | IKBKE | 0.89327009 |
58 | PAK3 | 0.89058057 |
59 | PRKD2 | 0.87405056 |
60 | EPHA4 | 0.87169039 |
61 | MARK1 | 0.85946823 |
62 | MARK3 | 0.83835131 |
63 | OXSR1 | 0.83646450 |
64 | JAK3 | 0.83342048 |
65 | BMPR1B | 0.79594109 |
66 | NLK | 0.79038941 |
67 | MAP3K3 | 0.77733586 |
68 | PIK3CG | 0.76914487 |
69 | MAP3K7 | 0.74367223 |
70 | CAMKK2 | 0.74144977 |
71 | TEC | 0.72415244 |
72 | FGFR3 | 0.72173821 |
73 | MAP3K5 | 0.69207611 |
74 | NEK9 | 0.67755274 |
75 | PNCK | 0.67431456 |
76 | PAK6 | 0.65586371 |
77 | BRD4 | 0.63537159 |
78 | ERBB2 | 0.62759036 |
79 | ERBB3 | 0.62728252 |
80 | SIK2 | 0.60538331 |
81 | MARK2 | 0.60492750 |
82 | PRKD3 | 0.59357736 |
83 | PLK2 | 0.57209414 |
84 | PKN1 | 0.56806769 |
85 | LCK | 0.56791030 |
86 | PRKCZ | 0.55689369 |
87 | STK10 | 0.55400569 |
88 | NUAK1 | 0.55056959 |
89 | CAMK4 | 0.54615933 |
90 | MAP3K13 | 0.53434801 |
91 | MAPK7 | 0.53059805 |
92 | FYN | 0.52510220 |
93 | ROCK2 | 0.51416876 |
94 | GRK5 | 0.50608976 |
95 | DYRK1A | 0.48650600 |
96 | DAPK2 | 0.48634373 |
97 | SGK1 | 0.48478550 |
98 | DYRK1B | 0.47424607 |
99 | MAP3K14 | 0.46036402 |
100 | ACVR1B | 0.44270947 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53930319 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.46121973 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.08438703 |
4 | Tuberculosis_Homo sapiens_hsa05152 | 2.02626142 |
5 | Malaria_Homo sapiens_hsa05144 | 1.99517714 |
6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.91214479 |
7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.86482263 |
8 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.75243970 |
9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73099344 |
10 | Legionellosis_Homo sapiens_hsa05134 | 1.66581256 |
11 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.63840868 |
12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62724223 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.54620915 |
14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.52329145 |
15 | Measles_Homo sapiens_hsa05162 | 1.49083150 |
16 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.48614783 |
17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38217615 |
18 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36070610 |
19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30200629 |
20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23581637 |
21 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.20567410 |
22 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18185593 |
23 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17335180 |
24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16803003 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14639277 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.12700699 |
27 | Phagosome_Homo sapiens_hsa04145 | 1.12309316 |
28 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.10075237 |
29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09680565 |
30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08776339 |
31 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07180267 |
32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03071115 |
33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02787598 |
34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01483265 |
35 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.00078183 |
36 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99564047 |
37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99105443 |
38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97941100 |
39 | Platelet activation_Homo sapiens_hsa04611 | 0.95491462 |
40 | * Hepatitis B_Homo sapiens_hsa05161 | 0.95299779 |
41 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.94378099 |
42 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92857724 |
43 | Morphine addiction_Homo sapiens_hsa05032 | 0.90875776 |
44 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.90790292 |
45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90240106 |
46 | Colorectal cancer_Homo sapiens_hsa05210 | 0.90238933 |
47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89697216 |
48 | Allograft rejection_Homo sapiens_hsa05330 | 0.89506740 |
49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89123813 |
50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88164310 |
51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85336890 |
52 | Axon guidance_Homo sapiens_hsa04360 | 0.85144287 |
53 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84602035 |
54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83871125 |
55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82679268 |
56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82482187 |
57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80873446 |
58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80062456 |
59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80011422 |
60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79344941 |
61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78995123 |
62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78876943 |
63 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76678003 |
64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76560322 |
65 | Hepatitis C_Homo sapiens_hsa05160 | 0.74672647 |
66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74580779 |
67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73554277 |
68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73274795 |
69 | Glioma_Homo sapiens_hsa05214 | 0.72838233 |
70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71848106 |
71 | Pertussis_Homo sapiens_hsa05133 | 0.70217019 |
72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69581326 |
73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69577557 |
74 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67423473 |
75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66750557 |
76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66235368 |
77 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65560573 |
78 | * Cholinergic synapse_Homo sapiens_hsa04725 | 0.64173236 |
79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63789227 |
80 | Long-term depression_Homo sapiens_hsa04730 | 0.63076663 |
81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.60713679 |
82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60595315 |
83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59452906 |
84 | Endocytosis_Homo sapiens_hsa04144 | 0.59197895 |
85 | Salmonella infection_Homo sapiens_hsa05132 | 0.57222247 |
86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56628579 |
87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56183867 |
88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56164803 |
89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54595433 |
90 | Apoptosis_Homo sapiens_hsa04210 | 0.54568443 |
91 | * Prostate cancer_Homo sapiens_hsa05215 | 0.54350139 |
92 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53934880 |
93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53342171 |
94 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52491736 |
95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52427245 |
96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52384127 |
97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52060486 |
98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50741181 |
99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49893150 |
100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48915702 |